For example, MPO inhibition with the irreversible inhibitor PF-1355 decreased both extracellular and intracellular MPO activities, reduced left ventricular dilation, and improved cardiac function and scar remodeling in a mouse model of MI [10]. This evidence concerns the gene MPO and myocardial infarction.